SEVENTH SENSE BIOSYSTEMS, INC.
Profile
Company Names
SEVENTH SENSE BIOSYSTEMS, INC.
Addresses
200 BOSTON AVENUE, SUITE 3700, MEDFORD, MA 02155
286 CARDINAL MEDEIROS AVENUE, CAMBRIDGE, MA 02141
101 BINNEY STREET, CAMBRIDGE, MA 02142
Phone Numbers
617-547-7246
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2007
State Incorporated:
DELAWARE
Total Amount Raised:
$66,695,765.00
Number of Funding Rounds:
16
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
16
2018-08-09
$18,458,837.00
$20,483,208.00
$2,024,371.00
Equity
15
2018-02-06
$3,459,381.00
$5,500,000.00
$2,040,619.00
Debt
14
2017-09-06
$2,500,000.00
$10,000,000.00
$7,500,000.00
Equity
13
2016-11-07
$5,500,000.00
$12,750,000.00
$7,250,000.00
Equity
12
2015-11-25
$2,060,000.00
$2,060,000.00
$0.00
Equity
11
2014-07-28
$14,287,084.00
$16,287,084.00
$2,000,000.00
Equity, Debt
10
2014-06-03
$450,000.00
$450,000.00
$0.00
Debt
9
2014-03-26
$930,000.00
$930,000.00
$0.00
Debt
8
2013-11-06
$360,000.00
INDEFINITE
INDEFINITE
Debt
7
2013-03-19
$157,500.00
$157,500.00
$0.00
6
2013-03-01
$1,800,000.00
$1,800,000.00
$0.00
Debt
5
2012-05-17
$200,000.00
$200,000.00
$0.00
Debt
4
2012-03-26
$750,000.00
$750,000.00
$0.00
Debt
3
2011-04-25
$12,182,963.00
$12,182,963.00
$0.00
Equity
2
2010-10-01
$2,100,000.00
$2,100,000.00
$0.00
Debt
1
2010-05-26
$1,500,000.00
$1,500,000.00
$0.00
Debt
People
First Name
Middle Name
Last Name
Titles
Related Companies
R.
ROX
ANDERSON
DIRECTOR
HOWARD
BERNSTEIN
EXECUTIVE OFFICER
DOUG
COLE
DIRECTOR
ALAN
CRANE
DIRECTOR
CERULEAN PHARMA INC.
| PARASOL THERAPEUTICS INC
| SEVENTH SENSE BIOSYSTEMS, INC.
| T2 BIOSYSTEMS, INC.
| VISTERRA, INC.
| EXPERIMENT FUND, LLC
| OCULAR THERAPEUTIX, INC
| CALORICS, INC.
| XTUIT PHARMACEUTICALS, INC.
| NAVITOR PHARMACEUTICALS, INC.
| PANDION THERAPEUTICS, INC.
| SEISMIC THERAPEUTIC, INC.
NEIL
EXTER
DIRECTOR
SEVENTH SENSE BIOSYSTEMS, INC.
| CORIDEA NC1, INC.
| CYTOMX THERAPEUTICS, INC.
| ELEMENT SCIENCE, INC.
| RHYTHM METABOLIC, INC.
| RHYTHM PHARMACEUTICALS, INC.
| GOLDFINCH BIOPHARMA, INC.
| PLIANT THERAPEUTICS, INC.
| THIRD ROCK VENTURES V, L.P.
| REVOLUTION MEDICINES, INC.
| GOLDFINCH BIO, INC.
| CEDILLA THERAPEUTICS, INC.
| DECIBEL THERAPEUTICS, INC.
| THIRD ROCK VENTURES VI, L.P.
PETER
HUTT
DIRECTOR
ROBERT
LANGER
DIRECTOR
MICROCHIPS, INC.
| ARSENAL MEDICAL, INC.
| ALSERES PHARMACEUTICALS INC /DE
| ECHO THERAPEUTICS, INC.
| MICELL TECHNOLOGIES INC
| CERULEAN PHARMA INC.
| HUMACYTE INC
| COMBINENT BIOMEDICAL SYSTEMS, INC.
| TARIS BIOMEDICAL INC
| KALA PHARMACEUTICALS, INC.
| FIBROCELL SCIENCE, INC.
| PREDICTIVE BIOSCIENCES, INC
| SEVENTH SENSE BIOSYSTEMS, INC.
| T2 BIOSYSTEMS, INC.
| SEMPRUS BIOSCIENCES CORP
| LIQUIDX, INC.
| ARSENAL VASCULAR, INC.
| ARSENAL MEDICAL, INC.
| SELECTA BIOSCIENCES INC
| STEMNION, INC.
| 480 BIOMEDICAL, INC.
| LIVING PROOF INC
| DX BIOSCIENCES, INC.
| MODERNA LLC
| HUMACYTE, INC
| XTUIT PHARMACEUTICALS, INC.
| SQZ BIOTECHNOLOGIES CO
| NOVEOME BIOTHERAPEUTICS, INC.
| LYNDRA, INC.
| MODERNA THERAPEUTICS, INC.
| VERSEAU THERAPEUTICS, INC.
| FREQUENCY THERAPEUTICS, INC.
| SUONO BIO, INC.
| COMBINED THERAPEUTICS, INC.
| HUMACYTE, INC.
| SEER BIOSCIENCES, INC.
| LANDSDOWNE LABS, LLC
| LIKEMINDS, INC./DE
| TARVEDA THERAPEUTICS, INC.
| LUMINOPIA, INC.
| LYRA THERAPEUTICS, INC.
| ABPRO CORP
| GLYMPSE BIO, INC.
| EPIBONE, INC.
| TEAL BIO, INC.
| ZWI THERAPEUTICS, INC.
| LYNDRA THERAPEUTICS, INC.
| KENDALL CAPITAL PARTNERS I, L.P.
| BILAYER THERAPEUTICS, INC.
| XENTER, INC.
| VIVTEX CORP
| SYNTIS BIO, INC.
| OMNIPULSE BIOSCIENCES, INC.
TIMOTHY
RICHARDS
EXECUTIVE OFFICER
HOWARD
WEISMAN
EXECUTIVE OFFICER, DIRECTOR
HARRY
WILCOX
DIRECTOR, EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
